2022
DOI: 10.17343/sdutfd.1100763
|View full text |Cite
|
Sign up to set email alerts
|

Si̇ldenafi̇l Si̇trat Ve Dekspantenolün Yara İyi̇leşmesi̇ Üzeri̇ndeki̇ Etki̇leri̇ni̇n Karşilaştirilmasi: Deneysel Çalişma

Abstract: Objective: Wound healing is a serious problem that causes high morbidity. Different pharmacological agents have been studied to accelerate wound healing and to prevent necrosis and ischemia, and still continue to work. Topical dexpanthenol is widely used in both wound healing and various dermatological diseases. The aim of this study was to compare the effects of topical sildenafil citrate and topical dexpanthenol on wound healing in rats. Material and Methods: A total of 30 female Wistar Albino rats, we… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 24 publications
0
0
0
Order By: Relevance
“…2 Oxidative/antioxidant balance disrupted by oxidative stress causes macro and microvascular complications of diabetes. 3,4 Sildenafil, known as a phosphodiesterase type 5 (PDE 5, the enzyme responsible for cGMP hydrolysis) inhibitor, is a therapeutic drug of choice in neurodegenerative diseases, 5 including age-related macular degeneration, used in the treatment of erectile dysfunction and pulmonary arterial hypertension. 6 It is known that sildenafil regulates vascular superoxide release by affecting nitric oxide (NO) release and reduces oxidative stress by causing a vascular antioxidant effect in insulin-resistant rats.…”
Section: Introductionmentioning
confidence: 99%
“…2 Oxidative/antioxidant balance disrupted by oxidative stress causes macro and microvascular complications of diabetes. 3,4 Sildenafil, known as a phosphodiesterase type 5 (PDE 5, the enzyme responsible for cGMP hydrolysis) inhibitor, is a therapeutic drug of choice in neurodegenerative diseases, 5 including age-related macular degeneration, used in the treatment of erectile dysfunction and pulmonary arterial hypertension. 6 It is known that sildenafil regulates vascular superoxide release by affecting nitric oxide (NO) release and reduces oxidative stress by causing a vascular antioxidant effect in insulin-resistant rats.…”
Section: Introductionmentioning
confidence: 99%